Skip to main content
CivicGate

HR 1178
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Alpha-gal Allergen Inclusion Act

To amend the Federal Food, Drug, and Cosmetic Act to add alpha-gal to the definition of ``major food allergen''.

Introduced Feb 10, 2025

Latest action (Feb 10, 2025) Referred to the House Committee on Energy and Commerce.

Referred to
Energy and Commerce Committee
Policy area
Health
Issues
Healthcare
Legislative subjects (1)
Allergies

Summary
  • Adds alpha-gal (galactose-alpha-1,3-galactose) to the list of major food allergens under the Federal Food, Drug, and Cosmetic Act.
  • Defines alpha-gal to include ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales.
  • Specifies that ingredients with no detectable levels of alpha-gal, such as those from genetically modified mammals, are not considered alpha-gal allergens.
  • Takes effect 18 months after enactment.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
46 cosponsors

Money behind the sponsor

Top reported contributors to Jefferson Van Drew’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • Employer not reported $176,557
  • ENTREPRENEUR $70,972
  • PULSE VASCULAR $9,900
  • ICONA RESORTS $9,900
  • MONZO CATANESE HILLEGASS $9,000

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jefferson Van Drew → · Outside spending →

Actions (2)
  1. Feb 10, 2025 Referred to the House Committee on Energy and Commerce. · house
  2. Feb 10, 2025 Introduced in House

More bills on these subjects (6)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

  • HR 9770 — Continuing Appropriations Act, 2027 (shares 1 subject)
  • HR 7148 — Consolidated Appropriations Act, 2026 (shares 1 subject)
  • S 2882 — Continuing Appropriations and Extensions and Other Matters Act, 2026 (shares 1 subject)
  • HR 5450 — Continuing Appropriations and Extensions and Other Matters Act, 2026 (shares 1 subject)
  • HR 1497 — NIH Reform Act (shares 1 subject)
  • HR 4627 — Food Biotechnology Information Initiative Act (shares 1 subject)

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • HR 3821 — ADINA Act · Introduced Jun 6, 2025 · Cong. 119 58%
  • HR 1051 — To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes. · Introduced Feb 6, 2025 · Cong. 119 52%
  • HR 7366 — Dietary Supplement Regulatory Uniformity Act · Introduced Feb 4, 2026 · Cong. 119 50%
  • HR 843 — Prompt Approval of Safe Generic Drugs Act · Introduced Jan 31, 2025 · Cong. 119 49%
  • HR 1843 — To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. · Introduced Mar 5, 2025 · Cong. 119 49%
  • S 1212 — LOCAL Foods Act of 2025 · Introduced Mar 31, 2025 · Cong. 119 48%

Text versions (1)
  • Introduced in House · Feb 10, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Committee action

What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.

Meetings where this bill was on the agenda

Full text

IN THE HOUSE OF REPRESENTATIVES

February 10, 2025

Mr. Van Drew (for himself, Mr. Murphy, Mr. Davis of North Carolina, Mr. Balderson, Mr. Carter of Texas, Mr. LaMalfa, Mr. Griffith, Mr. Magaziner, Mr. Moore of Alabama, Ms. Norton, Mr. Rulli, Mr. Cline, Mr. Wittman, Mrs. Cherfilus-McCormick, and Mr. Smith of New Jersey) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to add alpha-gal to the definition of “major food allergen”.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Alpha-gal Allergen Inclusion Act”.

SEC. 2. ADDING ALPHA-GAL TO DEFINITION OF “MAJOR FOOD ALLERGEN”.

(a) In General.—Section 201(qq) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(qq)) is amended by adding at the end the following:

“(3)(A) Galactose-alpha-1,3-galactose (commonly known as ‘alpha-gal’).

“(B) For purposes of this subparagraph, the term ‘galactose-alpha-1,3-galactose’ includes—

“(i) ingredients derived from non-catarrhine primate mammals; and

“(ii) red algae in the order Gigartinales.

“(C) For purposes of this subparagraph, the term ‘galactose-alpha-1,3-galactose’ does not include mammal-derived ingredients for which the Secretary determines there is no galactose-alpha-1,3-galactose above an established, detectable limit (such as ingredients made from alpha-gal-knockout mammals).”.

(b) Effective Date.—The amendment made by subsection (a) shall apply beginning on the date that is 18 months after the date of enactment of this Act. <all>

Comments

Comments

Loading comments…